These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12651288)

  • 1. Treatment of severe life-threatening graft-versus-host disease by autologous peripheral blood stem cell transplantation using a nonmyeloablative preconditioning regimen.
    Taniguchi Y; Ikegame K; Yoshihara S; Sugiyama H; Kawase I; Ogawa H
    Haematologica; 2003 Mar; 88(3):ELT06. PubMed ID: 12651288
    [No Abstract]   [Full Text] [Related]  

  • 2. The graft-versus-leukemia effect of nonmyeloablative stem cell allografts may not be sufficient to cure chronic myelogenous leukemia.
    Sloand E; Childs RW; Solomon S; Greene A; Young NS; Barrett AJ
    Bone Marrow Transplant; 2003 Nov; 32(9):897-901. PubMed ID: 14561990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
    Ozdogu H; Boga C; Kizilkilic E; Kozanoglu I; Karakus S; Sahin FI; Unalan D; Haberal M
    Transplant Proc; 2007 May; 39(4):1257-60. PubMed ID: 17524948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous/syngeneic stem cell transplantation to treat refractory GvHD.
    Passweg JR; Orchard K; Buergi A; Gratwohl A; Powles R; Goldman J; Apperley J; Mehta J
    Bone Marrow Transplant; 2004 Dec; 34(11):995-8. PubMed ID: 15489881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.
    Guo M; Sun Z; Sun QY; Han Q; Yu CL; Wang DH; Qiao JH; Chen B; Sun WJ; Hu KX; Liu GX; Liu B; Zhao RC; Ai H
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):930-7. PubMed ID: 19589482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of severe graft-versus-host disease after nonmyeloablative matched unrelated donor stem cell transplant by infusion of backup autologous peripheral blood stem cells.
    Khan SA; Moreb JS
    Bone Marrow Transplant; 2005 Aug; 36(3):267-8. PubMed ID: 15937501
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors.
    Petersen SL; Ryder LP; Björk P; Madsen HO; Heilmann C; Jacobsen N; Sengeløv H; Vindeløv LL
    Bone Marrow Transplant; 2003 Jul; 32(1):65-72. PubMed ID: 12815480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reduced intensity conditioning regimen for allografting following autografting is feasible and has strong anti-myeloma activity.
    Carella AM; Beltrami G; Corsetti MT; Scalzulli P; Carella AM; Musto P
    Haematologica; 2004 Dec; 89(12):1534-6. PubMed ID: 15590410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells.
    Corradini P; Dodero A; Zallio F; Caracciolo D; Casini M; Bregni M; Narni F; Patriarca F; Boccadoro M; Benedetti F; Rambaldi A; Gianni AM; Tarella C
    J Clin Oncol; 2004 Jun; 22(11):2172-6. PubMed ID: 15169805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of donor graft failure with nonmyeloablative conditioning of fludarabine, antithymocyte globulin and a second allogeneic hematopoietic transplantation.
    Jabbour E; Rondon G; Anderlini P; Giralt SA; Couriel DR; Champlin RE; Khouri IF
    Bone Marrow Transplant; 2007 Sep; 40(5):431-5. PubMed ID: 17603511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation.
    Musso M; Porretto F; Crescimanno A; Polizzi V; Scalone R
    Bone Marrow Transplant; 2004 Apr; 33(7):769-71. PubMed ID: 14755320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
    Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
    Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
    Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating graft-versus-host disease to enhance the graft-versus-leukemia effect.
    Alyea EP
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):239-50. PubMed ID: 18503989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of hepatic graft-versus-host disease complicating autologous stem cell transplantation for relapsed Hodgkin's disease.
    Cutting R; Wright J; Underwood J
    Bone Marrow Transplant; 2006 Jul; 38(1):77-8. PubMed ID: 16715105
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effect.
    Alyea E; Weller E; Schlossman R; Canning C; Mauch P; Ng A; Fisher D; Gribben J; Freeman A; Parikh B; Richardson P; Soiffer R; Ritz J; Anderson KC
    Bone Marrow Transplant; 2003 Dec; 32(12):1145-51. PubMed ID: 14647268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous peripheral blood stem cell transplantation with induction of autologous graft-versus-host disease in acute myeloid leukemia.
    Park J; Lee MH; Lee HR; Park SH; Lee SH; Lee KE; Lee H; Park JO; Kim K; Jung CW; Im YH; Kang WK; Ko YH; Park K
    Bone Marrow Transplant; 2003 Nov; 32(9):889-95. PubMed ID: 14561989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-T-cell-depleted HLA-haploidentical stem cell transplantation after reduced-intensity conditioning in advanced haematological malignancies based on feto-maternal microchimerism.
    Shimazaki C; Fuchida S; Ochiai N; Nakano S; Yamada N; Uchida R; Okamoto M; Okano A; Inaba T; Maruya E; Saji H
    Br J Haematol; 2004 Nov; 127(4):474-5. PubMed ID: 15521926
    [No Abstract]   [Full Text] [Related]  

  • 20. [The clinical research of nonmyeloablative allogeneic peripheral blood hematopoietic stem cells transplantation for hematological diseases].
    Ai HS; Yu CL; Wang DH; Guo M; Qiao JH; Shi BF; Sun WJ; Zhang S; Sun QY; Yao B
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):86-9. PubMed ID: 12697103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.